Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13717
Country/Region: Uganda
Year: 2016
Main Partner: Uganda Episcopal Conference
Main Partner Program: Registered Trustees
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $7,180,310 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,539,404
Care: Orphans and Vulnerable Children (HKID) $491,350
Care: TB/HIV (HVTB) $367,792
Care: Pediatric Care and Support (PDCS) $480,849
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $177,927
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $529,868
Sexual Prevention: Other Sexual Prevention (HVOP) $54,289
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $288,616
Treatment: Adult Treatment (HTXS) $3,094,319
Treatment: Pediatric Treatment (PDTX) $155,898
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 110
GEND_GBV Age/Sex: <10 Male 2017 66
GEND_GBV Age/Sex: 10-14 Female 2017 309
GEND_GBV Age/Sex: 10-14 Male 2017 66
GEND_GBV Age/Sex: 15-19 Female 2017 548
GEND_GBV Age/Sex: 15-19 male 2017 112
GEND_GBV Age/Sex: 20-24 Female 2017 550
GEND_GBV Age/Sex: 20-24 Male 2017 110
GEND_GBV Age/Sex: 25-49 Female 2017 220
GEND_GBV Age/Sex: 25-49 Male 2017 110
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 198
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 483
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,718
GEND_GBV Number of people receiving post-GBV care 2017 2,201
GEND_GBV Sum of Age/Sex Disaggregates 2017 551
HTS_TST Age/sex: <1 2017 2,743
HTS_TST Age/sex: 1-9 2017 9,042
HTS_TST Age/sex: 10-14 Female 2017 7,807
HTS_TST Age/sex: 10-14 Male 2017 7,805
HTS_TST Age/sex: 15-19 Female 2017 19,994
HTS_TST Age/sex: 15-19 Male 2017 20,844
HTS_TST Age/sex: 20-24 Female 2017 29,990
HTS_TST Age/sex: 20-24 Male 2017 31,267
HTS_TST Age/sex: 25-49 Female 2017 45,985
HTS_TST Age/sex: 25-49 Male 2017 47,941
HTS_TST Age/sex: 50+ Female 2017 3,998
HTS_TST Age/sex: 50+ Male 2017 4,168
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 13,703
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 13,694
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 99,967
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 104,220
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 231,584
HTS_TST Service Delivery Point (Facility): Index testing 2017 17,069
HTS_TST Service Delivery Point (Facility): Inpatient 2017 47,469
HTS_TST Service Delivery Point (Facility): Other PITC 2017 13,940
HTS_TST Service Delivery Point (Facility): Outpatient 2017 60,132
HTS_TST Service Delivery Point (Facility): Pediatric 2017 24,600
HTS_TST Service Delivery Point (Facility): PMTCT 2017 38,933
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,941
HTS_TST Service Delivery Point (Facility): VMMC 2017 27,500
HTS_TST Sum of Age/Sex disaggregates 2017 219,799
HTS_TST Sum of Aggregated Age/Sex <15 2017 27,397
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 204,187
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 231,584
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 356
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 351
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 929
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 593
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,397
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 890
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 2,139
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1,363
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 185
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 119
HTS_TST_POS Test Result by Age: Positive: <1 2017 120
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 408
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 620
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 615
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,650
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,965
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,636
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,636
KP_PREV Total estimated number of key population in the catchment area 2017 3,353
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 3,353
OVC_SERV Age/Sex: 18+ Female 2017 1,055
OVC_SERV Age/Sex: 18+ Male 2017 873
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 3,015
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 2,814
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 7,757
OVC_SERV Sum of Age/Sex disaggregates 2017 1,928
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,971
PMTCT_ART New on ART 2017 1,420
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 39,197
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2,236
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 625
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 28
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 112
PMTCT_EID Sum of Infant Age disaggregates 2017 2,861
PMTCT_STAT By: Known positives at entry 2017 2,152
PMTCT_STAT By: Number of new positives identified 2017 1,425
PMTCT_STAT Number of new ANC and L&D clients 2017 40,204
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 39,197
PMTCT_STAT Sum of Positives Status disaggregates 2017 3,577
PP_PREV Aggregated Age/sex: <15 Female 2017 416
PP_PREV Aggregated Age/sex: <15 Male 2017 383
PP_PREV Aggregated Age/sex: 15+ Female 2017 488
PP_PREV Aggregated Age/sex: 15+ Male 2017 490
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 1,768
PP_PREV Total number of people in the target population 2017 6,090
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 17
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 447
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 23
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 816
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,303
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,303
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 5,454
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 546
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,637
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,271
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,363
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 42,100
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 21,681
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,329
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,064
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 68,174
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 82
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,129
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 107
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2,046
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,364
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,364
TX_CURR Age/Sex: <1 2017 174
TX_CURR Age/Sex: <1-9 2017 1,054
TX_CURR Age/Sex: 10-14 Female 2017 1,700
TX_CURR Age/Sex: 10-14 Male 2017 1,465
TX_CURR Age/Sex: 15-19 Female 2017 2,106
TX_CURR Age/Sex: 15-19 Male 2017 651
TX_CURR Age/Sex: 20-24 Female 2017 9,682
TX_CURR Age/Sex: 20-24 Male 2017 4,335
TX_CURR Age/Sex: 25-49 Female 2017 28,206
TX_CURR Age/Sex: 25-49 Male 2017 15,612
TX_CURR Age/Sex: 50+ Female 2017 2,106
TX_CURR Age/Sex: 50+ Male 2017 1,083
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,329
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,064
TX_CURR Aggregated Age/Sex: 15+ Female 2017 42,100
TX_CURR Aggregated Age/Sex: 15+ Male 2017 21,681
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 68,174
TX_CURR Sum of age/sex disaggregates 2017 2,757
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,393
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 63,781
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 68,174
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 564
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 502
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 7,486
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,864
TX_NEW By Age/Sex: <1 2017 40
TX_NEW By Age/Sex: 1-9 2017 256
TX_NEW By Age/Sex: 10-14 Female 2017 413
TX_NEW By Age/Sex: 10-14 Male 2017 357
TX_NEW By Age/Sex: 15-19 Female 2017 375
TX_NEW By Age/Sex: 15-19 Male 2017 116
TX_NEW By Age/Sex: 20-24 Female 2017 1,722
TX_NEW By Age/Sex: 20-24 Male 2017 774
TX_NEW By Age/Sex: 25-49 Female 2017 5,016
TX_NEW By Age/Sex: 25-49 Male 2017 2,784
TX_NEW By Age/Sex: 50+ Female 2017 373
TX_NEW By Age/Sex: 50+ Male 2017 190
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 12,416
TX_NEW Sum of Age/Sex disaggregates 2017 12,120
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 12,416
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 54,540
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 49,087
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,675
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,484
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 30,300
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 15,628
TX_PVLS Numerator: Indication: Routine 2017 49,087
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,862
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,653
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 33,672
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 17,353
TX_PVLS_den Denominator: Indication: Routine 2017 54,540
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 121
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 163
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 186
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 182
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 231
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 830
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,415
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,478
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 177
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,855
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 225
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 263
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,604
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7,609
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 11,701
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 13,149
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 132
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 186
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 210
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 202
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 258
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 929
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,712
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,714
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,157
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 205
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 422
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 254
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 296
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,050
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,549
VMMC_CIRC By Age: 10-14 2017 10,724
VMMC_CIRC By Age: 15-19 2017 7,975
VMMC_CIRC By Age: 20-24 2017 3,849
VMMC_CIRC By Age: 25-29 2017 2,201
VMMC_CIRC By Age: 30-49 2017 2,201
VMMC_CIRC By Age: 50+ 2017 550
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 27,500
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 27,500
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 27,500
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 23,098